CHOP study uncovers metabolic key to faster immune response

Researchers from Children’s Hospital of Philadelphia identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently recognize pathogens, vaccines, or diseased cells grow and divide faster than other cells.

Edwards, Medtronic post low-risk TAVR data, allaying fears of market disruption

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Edwards Lifesciences and Medtronic reported

October 25, 2023

Awakn Life Sciences Announces Closing of Tranche of Private Placement | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – April 17, 2024) – Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology

April 17, 2024

Booster launches to develop proteasome activator medicines

The company will focus on creating small molecule therapeutics that enhance the natural function of proteasomes. Credit: Gorodenkoff/Shutterstock. Booster Therapeutics has announced its inception, backed

October 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.